Literature DB >> 3495695

Risk factors for HIV infection in German i.v. drug abusers. Clinical, serological and epidemiological features.

G Harms, U Laukamm-Josten, U Bienzle, I Guggenmoos-Holzmann.   

Abstract

A series of 320 German i.v. drug abusers (32.2% female, 67.8% male) were tested in a cross-sectional study for antibodies against HIV. Seroprevalence increased from 0 in those who discontinued i.v. drug abuse before 1982 to 37.2% in those who stopped injecting drugs in 1985/1986 or who were still addicted. Antibodies to HIV were significantly associated with lymphadenopathy and clinical symptoms (fever, weight loss, diarrhea, fatigue, night sweat, dermal lesions) and with markers of hepatitis A and hepatitis B virus infection. Participants of the study admitted in 92.5% of cases to "needle sharing" and in 83.1% of cases to sexual contacts among drug abusers. Prostitution and drug abuse in prison were significantly correlated with seropositivity. No antibodies to HIV infection were detected in 131 subjects of a control group of household contacts.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3495695     DOI: 10.1007/BF01745578

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  15 in total

1.  Anal intercourse as a possible factor in heterosexual transmission of HTLV-III to spouses of hemophiliacs.

Authors:  M Melbye; J Ingerslev; R J Biggar; S Alexander; P S Sarin; J J Goedert; E Zachariae; P Ebbesen; S Stenbjerg
Journal:  N Engl J Med       Date:  1985-03-28       Impact factor: 91.245

2.  Seroepidemiology of HTLV-III (LAV) in the Federal Republic of Germany.

Authors:  G Hunsmann; J Schneider; H Bayer; R Kurth; A Werner; H D Brede; V Erfle; W Mellert; H R Brodt; L Bergmann
Journal:  Klin Wochenschr       Date:  1985-03-01

3.  HTLV-III antibodies in an Edinburgh clinic.

Authors:  R P Brettle; J Davidson; S J Davidson; J M Gray; J M Inglis; J S Conn; G E Bath; J Gillon; D B McClelland
Journal:  Lancet       Date:  1986-05-10       Impact factor: 79.321

4.  Female-to-male transmission of AIDS agent.

Authors:  R F Wykoff
Journal:  Lancet       Date:  1985-11-02       Impact factor: 79.321

5.  HTLV-III antibody in Edinburgh drug addicts.

Authors:  J F Peutherer; E Edmond; P Simmonds; J D Dickson; G E Bath
Journal:  Lancet       Date:  1985-11-16       Impact factor: 79.321

6.  High frequency of HTLV-III antibodies among heterosexual intravenous drug abusers in the Austrian Tyrol.

Authors:  D Fuchs; H G Blecha; F Deinhardt; M P Dierich; F D Goebel; P Hengster; H Hinterhuber; D Schoenitzer; K Traill; H Wachter
Journal:  Lancet       Date:  1985-06-29       Impact factor: 79.321

7.  HTLV-III antibody among Italian drug addicts.

Authors:  P Ferroni; D Geroldi; C Galli; A R Zanetti; A Cargnel
Journal:  Lancet       Date:  1985-07-06       Impact factor: 79.321

8.  Rapid spread of HTLV-III infection among drug addicts in Italy.

Authors:  G Angarano; G Pastore; L Monno; T Santantonio; N Luchena; O Schiraldi
Journal:  Lancet       Date:  1985-12-07       Impact factor: 79.321

9.  HTLV-III antibody in Swiss and English intravenous drug abusers.

Authors:  P P Mortimer; E M Vandervelde; W J Jesson; M S Pereira; F Burkhardt
Journal:  Lancet       Date:  1985-08-24       Impact factor: 79.321

10.  HTLV-III antibody in drug abusers in the west of Scotland: the Edinburgh connection.

Authors:  E A Follett; A McIntyre; B O'Donnell; G B Clements; U Desselberger
Journal:  Lancet       Date:  1986-02-22       Impact factor: 79.321

View more
  3 in total

1.  HIV infection in intravenous drug abusers in Berlin: risk factors and time trends.

Authors:  K Stark; R Müller; I Guggenmoos-Holzmann; S Deininger; E Meyer; U Bienzle
Journal:  Klin Wochenschr       Date:  1990-04-17

2.  Behavioral characteristics and laboratory parameters in homo- and bisexual men in West Berlin: an evaluation of five years of testing and counselling on AIDS.

Authors:  S Deininger; R Müller; I Guggenmoos-Holzmann; U Laukamm-Josten; U Bienzle
Journal:  Klin Wochenschr       Date:  1990-09-14

3.  Differences in time of virus appearance in the blood and virus-specific immune responses in intravenous and intrarectal primary SIVmac251 infection of rhesus macaques; a pilot study.

Authors:  L Stevceva; E Tryniszewska; Z Hel; J Nacsa; B Kelsall; R Washington Parks; G Franchini
Journal:  BMC Infect Dis       Date:  2001-07-27       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.